eric topol glp-1 The surprising result for a pill (orforglipron) is the magnitude of weight loss in a Phase 3 trial of participants with Type 2 diabetes. For still unexplained reasons, people with diabetes A Big Week for GLP-1

Freshly baked in small batches and carefully packed for freshness

GLP-1s show potential to be a miracle drug for addiction.

Medically guided weight care with a holistic plan

Endothelial dysfunction is a significant component of HFpEF pathophysiology, and glucagon-like peptide-1 receptor (GLP-1R) agonists have shown potential benefits in improving endothelial function

Discover how clinical trials in the UK could offer study-related access to GLP-1 medicines with no prescription costs.

Prader-Willi syndrome treatment involves interventions to control symptoms, as there are currently no therapies addressing its cause.